We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Recognize GMP Inspections From Eight EU Countries
FDA to Recognize GMP Inspections From Eight EU Countries
The FDA will begin to recognize manufacturing facility inspections conducted by drug regulatory authorities in Austria, Croatia, France, Italy, Malta, Spain, Sweden and the U.K as capable of meeting the agency’s requirements, as part of 1998 agreement between the U.S. and the European Union renegotiated earlier this year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor